Opioids Market Size, Share, Growth, and Industry Analysis, By Type (Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Others), By Application (Pain Management, Cough Treatment, Diarrhea Treatment), Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Opioids Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Opioids Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Opioids Business Mode and Production Process
2.3.1 Opioids Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Opioids Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Opioids
2.4.2 Raw Material Cost of Opioids
2.4.3 Labor Cost of Opioids
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Opioids Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Opioids Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Opioids Price by Manufacturer (2021-2026)
4.4 Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Opioids, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Opioids, Product Offered and Application
4.7 Opioids Market Competitive Situation and Trends
4.7.1 Opioids Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Opioids Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Opioids Market Historical Development by Geographic Region (2021-2026)
5.1 Global Opioids Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Opioids Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Opioids Market Status by Country (2021-2026)
5.3.1 North America Opioids Sales Volume by Country (2021-2026)
5.3.2 North America Opioids Revenue by Country (2021-2026)
5.3.3 United States Opioids Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Opioids Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Opioids Market Status by Country (2021-2026)
5.4.1 Europe Opioids Sales Volume by Country (2021-2026)
5.4.2 Europe Opioids Revenue by Country (2021-2026)
5.4.3 Germany Opioids Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Opioids Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Opioids Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Opioids Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Opioids Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Opioids Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Opioids Market Status by Country (2021-2026)
5.5.1 Asia Pacific Opioids Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Opioids Revenue by Country (2021-2026)
5.5.3 China Opioids Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Opioids Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Opioids Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Opioids Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Opioids Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Opioids Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Opioids Market Status by Country (2021-2026)
5.6.1 Latin America Opioids Sales Volume by Country (2021-2026)
5.6.2 Latin America Opioids Revenue by Country (2021-2026)
5.6.3 Mexico Opioids Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Opioids Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Opioids Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Opioids Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Opioids Revenue by Country (2021-2026)
5.7.3 GCC Opioids Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Opioids Sales Volume, Revenue and Growth (2021-2026)

6 Global Opioids Market Historical Development by Product Type (2021-2026)
6.1 Opioids Definition by Type
6.2 Global Opioids Historical Sales Volume by Product Type (2021-2026)
6.3 Global Opioids Historical Revenue by Product Type (2021-2026)
6.4 Global Opioids Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Methadone (2021-2026)
6.5.2 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Codeine (2021-2026)
6.5.3 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Fentanyl (2021-2026)
6.5.4 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Oxycodone (2021-2026)
6.5.5 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Morphine (2021-2026)
6.5.6 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Hydrocodone (2021-2026)
6.5.7 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

7 Global Opioids Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Opioids Historical Sales Volume by End User (2021-2026)
7.3 Global Opioids Historical Revenue by End User (2021-2026)
7.4 Global Opioids Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Pain Management (2021-2026)
7.5.2 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Cough Treatment (2021-2026)
7.5.3 Global Opioids Historical Sales Volume, Revenue and Growth Rate of Diarrhea Treatment (2021-2026)

8 Leading Companies Profiles
8.1 C.H. Boehringer Sohn Ag and Ko. Kg
8.1.1 C.H. Boehringer Sohn Ag and Ko. Kg Corporation Information
8.1.2 C.H. Boehringer Sohn Ag and Ko. Kg - Opioids Product Portfolio and Specification
8.1.3 C.H. Boehringer Sohn Ag and Ko. Kg Performance Analysis (2021-2026)
8.1.4 C.H. Boehringer Sohn Ag and Ko. Kg Business and Markets Served
8.1.5 C.H. Boehringer Sohn Ag and Ko. Kg Recent Developments
8.2 Mallinckrodt Pharmaceuticals
8.2.1 Mallinckrodt Pharmaceuticals Corporation Information
8.2.2 Mallinckrodt Pharmaceuticals - Opioids Product Portfolio and Specification
8.2.3 Mallinckrodt Pharmaceuticals Performance Analysis (2021-2026)
8.2.4 Mallinckrodt Pharmaceuticals Business and Markets Served
8.2.5 Mallinckrodt Pharmaceuticals Recent Developments
8.3 AstraZeneca Plc
8.3.1 AstraZeneca Plc Corporation Information
8.3.2 AstraZeneca Plc - Opioids Product Portfolio and Specification
8.3.3 AstraZeneca Plc Performance Analysis (2021-2026)
8.3.4 AstraZeneca Plc Business and Markets Served
8.3.5 AstraZeneca Plc Recent Developments
8.4 Sun Pharmaceuticals
8.4.1 Sun Pharmaceuticals Corporation Information
8.4.2 Sun Pharmaceuticals - Opioids Product Portfolio and Specification
8.4.3 Sun Pharmaceuticals Performance Analysis (2021-2026)
8.4.4 Sun Pharmaceuticals Business and Markets Served
8.4.5 Sun Pharmaceuticals Recent Developments
8.5 Johnson & Johnson, Inc..
8.5.1 Johnson & Johnson, Inc.. Corporation Information
8.5.2 Johnson & Johnson, Inc.. - Opioids Product Portfolio and Specification
8.5.3 Johnson & Johnson, Inc.. Performance Analysis (2021-2026)
8.5.4 Johnson & Johnson, Inc.. Business and Markets Served
8.5.5 Johnson & Johnson, Inc.. Recent Developments
8.6 Purdue Pharma LP
8.6.1 Purdue Pharma LP Corporation Information
8.6.2 Purdue Pharma LP - Opioids Product Portfolio and Specification
8.6.3 Purdue Pharma LP Performance Analysis (2021-2026)
8.6.4 Purdue Pharma LP Business and Markets Served
8.6.5 Purdue Pharma LP Recent Developments
8.7 Endo Pharmaceuticals Inc
8.7.1 Endo Pharmaceuticals Inc Corporation Information
8.7.2 Endo Pharmaceuticals Inc - Opioids Product Portfolio and Specification
8.7.3 Endo Pharmaceuticals Inc Performance Analysis (2021-2026)
8.7.4 Endo Pharmaceuticals Inc Business and Markets Served
8.7.5 Endo Pharmaceuticals Inc Recent Developments
8.8 Sanofi S.A.
8.8.1 Sanofi S.A. Corporation Information
8.8.2 Sanofi S.A. - Opioids Product Portfolio and Specification
8.8.3 Sanofi S.A. Performance Analysis (2021-2026)
8.8.4 Sanofi S.A. Business and Markets Served
8.8.5 Sanofi S.A. Recent Developments
8.9 Pfizer, Inc.
8.9.1 Pfizer, Inc. Corporation Information
8.9.2 Pfizer, Inc. - Opioids Product Portfolio and Specification
8.9.3 Pfizer, Inc. Performance Analysis (2021-2026)
8.9.4 Pfizer, Inc. Business and Markets Served
8.9.5 Pfizer, Inc. Recent Developments
8.10 Teva Pharmaceutical Industries Limited
8.10.1 Teva Pharmaceutical Industries Limited Corporation Information
8.10.2 Teva Pharmaceutical Industries Limited - Opioids Product Portfolio and Specification
8.10.3 Teva Pharmaceutical Industries Limited Performance Analysis (2021-2026)
8.10.4 Teva Pharmaceutical Industries Limited Business and Markets Served
8.10.5 Teva Pharmaceutical Industries Limited Recent Developments

9 Global Opioids Market Forecast by Product Type and End User (2026-2034)
9.1 Global Opioids Market Forecast by Product Type (2026-2034)
9.1.1 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Methadone (2026-2034)
9.1.2 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Codeine (2026-2034)
9.1.3 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Fentanyl (2026-2034)
9.1.4 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Oxycodone (2026-2034)
9.1.5 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Morphine (2026-2034)
9.1.6 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Hydrocodone (2026-2034)
9.1.7 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
9.2 Global Opioids Market Forecast by End User (2026-2034)
9.2.1 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Pain Management (2026-2034)
9.2.2 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Cough Treatment (2026-2034)
9.2.3 Global Opioids Sales Volume, Revenue Forecast and Growth Rate of Diarrhea Treatment (2026-2034)

10 Global Opioids Market Forecast by Geographic Region (2026-2034)
10.1 Global Opioids Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Opioids Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer